Duncan-Williams initiates coverage on Symmetry Medical (NYSE: SMA) with a Buy rating. PT $13.

Duncan analyst says, "We believe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE